E-viri
PDF
Recenzirano
Odprti dostop
-
Verheijen, Remy B.; Yu, Huixin; Schellens, Jan H.M.; Beijnen, Jos H.; Steeghs, Neeltje; Huitema, Alwin D.R.
Clinical pharmacology and therapeutics, November 2017, Letnik: 102, Številka: 5Journal Article
Despite the fact that pharmacokinetic exposure of kinase inhibitors (KIs) is highly variable and clear relationships exist between exposure and treatment outcomes, fixed dosing is still standard practice. This review aims to summarize the available clinical pharmacokinetic and pharmacodynamic data into practical guidelines for individualized dosing of KIs through therapeutic drug monitoring (TDM). Additionally, we provide an overview of prospective TDM trials and discuss the future steps needed for further implementation of TDM of KIs.
